MUSTANG BIO, INC. (Nasdaq:MBIO)
Health Care/Life Sciences • Biotechnology
CIK 1680048
Company
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Address
377 Plantation Street
1st floor
Worcester, Massachusetts 01605-2245
377 Plantation Street
1st floor
Worcester, Massachusetts 01605-2245
Employees
113
113
Stock Info
Close
$1.3500
$1.3500
Day Range
1.2900 - 1.4000
1.2900 - 1.4000
52 Week Range
1.2100 - 8.1700
1.2100 - 8.1700
Average volume
54.23K
54.23K
Short Interest
42.68K (02/15/24)
42.68K (02/15/24)
% of Float Shorted
0.58%
0.58%
Market Cap
$13.59M
$13.59M
Revenue
N/A
N/A
Net Income
-$77.53M
-$77.53M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman Michael Sean Weiss |
President, Chief Executive Officer & Director Manuel Litchman MD |
Non-Executive Director Lindsay Allan Rosenwald MD |
Independent Non-Executive Director Neil Herskowitz |
Independent Director Michael J Zelefsky MD |
Independent Non-Executive Director Adam Jeremy Chill |
SEC filings
Date | Form | Event |
---|---|---|
16 Aug, 2024 | 424B5 | |
13 Aug, 2024 | 10-Q | |
29 Jul, 2024 | EFFECT | |
25 Jul, 2024 | CORRESP | |
25 Jul, 2024 | UPLOAD | |
19 Jul, 2024 | S-1 | |
10 Jul, 2024 | DEF 14C | |
3 Jul, 2024 | 8-K | |
3 Jul, 2024 | 424B5 | |
28 Jun, 2024 | PRE 14C | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | SC 13D/A | |
24 Jun, 2024 | D | |
24 Jun, 2024 | 8-K | |
21 Jun, 2024 | 424B5 | |
20 Jun, 2024 | 424B5 | |
12 Jun, 2024 | EFFECT | |
10 Jun, 2024 | CORRESP | |
6 Jun, 2024 | 8-K | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | UPLOAD | |
4 Jun, 2024 | 4 | |
31 May, 2024 | S-3 | |
21 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
13 May, 2024 | 424B3 | |
2 May, 2024 | 8-K | |
1 May, 2024 | 424B4 | |
29 Apr, 2024 | S-1/A | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | CORRESP | |
29 Apr, 2024 | EFFECT | |
29 Apr, 2024 | EFFECT | |
29 Apr, 2024 | 8-K | |
29 Apr, 2024 | S-1/A | |
29 Apr, 2024 | S-1/A | |
12 Apr, 2024 | 8-K | |
2 Apr, 2024 | S-1/A | |
29 Mar, 2024 | 8-K | |
20 Mar, 2024 | UPLOAD | |
15 Mar, 2024 | 8-K | |
15 Mar, 2024 | S-1 | |
11 Mar, 2024 | 10-K | |
11 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | 8-K | |
12 Feb, 2024 | 3 | |
25 Jan, 2024 | 8-K | |
4 Jan, 2024 | 8-K | |
3 Jan, 2024 | 4 | |
19 Dec, 2023 | 3 | |
18 Dec, 2023 | UPLOAD | |
12 Dec, 2023 | S-1 | |
12 Dec, 2023 | 8-K | CEO Change |
11 Dec, 2023 | 8-K | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
3 Nov, 2023 | D | |
2 Nov, 2023 | 8-K | |
30 Oct, 2023 | 424B5 | |
30 Oct, 2023 | 8-K | |
26 Oct, 2023 | 8-K | |
4 Oct, 2023 | 8-K | |
6 Sep, 2023 | UPLOAD | |
28 Aug, 2023 | CORRESP | |
23 Aug, 2023 | UPLOAD | |
16 Aug, 2023 | 8-K | |
14 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
1 Aug, 2023 | S-8 | |
31 Jul, 2023 | 8-K | |
20 Jul, 2023 | 8-K | |
11 Jul, 2023 | 8-K | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
7 Jul, 2023 | 4 | |
30 Jun, 2023 | 8-K | |
23 Jun, 2023 | 8-K | |
22 May, 2023 | 8-K | |
12 May, 2023 | 8-K | |
12 May, 2023 | 10-Q | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | DEFA14A | |
20 Apr, 2023 | 8-K | |
14 Apr, 2023 | 424B5 | |
13 Apr, 2023 | 8-K | |
6 Apr, 2023 | 3/A | |
6 Apr, 2023 | 3/A | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 8-K | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
3 Apr, 2023 | 4 | |
30 Mar, 2023 | 10-K | |
29 Mar, 2023 | 8-K | |
13 Mar, 2023 | DEF 14C | |
3 Mar, 2023 | PRE 14C | |
3 Mar, 2023 | 8-K | |
13 Jan, 2023 | SC 13D/A | |
6 Jan, 2023 | 4 | |
13 Dec, 2022 | 8-K | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
15 Jul, 2022 | S-8 | |
8 Jul, 2022 | SC 13G | |
7 Jul, 2022 | 8-K | |
24 Jun, 2022 | 8-K | |
7 Jun, 2022 | 3 | |
31 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
12 May, 2022 | 8-K | |
29 Apr, 2022 | DEFA14A | |
29 Apr, 2022 | DEF 14A | |
22 Apr, 2022 | 8-K | |
19 Apr, 2022 | PRE 14A | |
23 Mar, 2022 | 8-K | |
23 Mar, 2022 | 10-K | |
17 Mar, 2022 | 8-K | |
8 Mar, 2022 | 8-K | |
4 Feb, 2022 | SC 13G | |
16 Dec, 2021 | 4 | |
12 Nov, 2021 | 8-K | |
12 Nov, 2021 | 10-Q | |
8 Nov, 2021 | 4 | |
21 Oct, 2021 | 4 | |
28 Sep, 2021 | 8-K | |
24 Sep, 2021 | 4 | |
24 Sep, 2021 | 8-K | |
24 Sep, 2021 | 4 | |
16 Aug, 2021 | 10-Q | |
16 Aug, 2021 | 8-K | |
5 Aug, 2021 | 4 | |
30 Jul, 2021 | S-8 | |
30 Jul, 2021 | S-8 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
22 Jun, 2021 | 8-K | |
15 Jun, 2021 | PX14A6G | |
24 May, 2021 | EFFECT | |
20 May, 2021 | CORRESP | |
20 May, 2021 | S-3/A | |
14 May, 2021 | 8-K | |
14 May, 2021 | 10-Q | |
30 Apr, 2021 | DEF 14A | |
30 Apr, 2021 | DEFA14A | |
29 Apr, 2021 | 4 | |
28 Apr, 2021 | UPLOAD | |
23 Apr, 2021 | S-3 | |
20 Apr, 2021 | PRE 14A | |
16 Apr, 2021 | 4 | |
12 Apr, 2021 | SC 13G/A | |
2 Apr, 2021 | S-8 | |
24 Mar, 2021 | 8-K | |
24 Mar, 2021 | 10-K | |
15 Mar, 2021 | 4 | |
15 Mar, 2021 | 4 | |
15 Mar, 2021 | 4 | |
2 Feb, 2021 | SC 13G | |
2 Dec, 2020 | CORRESP | |
2 Nov, 2020 | UPLOAD |
Last update:2024-03-06 12:08:28.604213
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.